Menu
English
Stock Code: 00512.HK

Information Disclosure

Home
Information Disclosure

Contact Us

Units 3302, 33/F, The Center, 99 Queen's Road Central, Hong Kong

ir@chinagrandpharm.com

www.chinagrandpharm.com

Pages Links

Company Profile

Investor Relations

Legal Statement

Recent News

First Patient Dosed in the Phase 1b Clinical Trial for Sepsis of GP (HK)’s World-Class Innovative Drug STC3141 Promote Commercialization of Technological Innovation Pipelines Globally at Full Speed First-mover Advantages in Anti-virus and Anti-infection Area Come into Play

2020-12-13
GP (HK)’s Associate Sirtex Enters into Transactions and Strategic Cooperation with Nanospectra and BlackSwan Expands the Group’s Product Portfolio in Precision Interventional Diagnostics and Treatment and Continues to Propel Global Planning of Technological Innovation

2020-12-9

© 2021. China Grand Pharmaceutical and Healthcare Holdings Limited All Rights Reserved.